These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6377802)

  • 1. The clinical effect of the GABA-agonist, progabide, on spasticity.
    Mondrup K; Pedersen E
    Acta Neurol Scand; 1984 Apr; 69(4):200-6. PubMed ID: 6377802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the GABA-agonist, progabide, on stretch and flexor reflexes and on voluntary power in spastic patients.
    Mondrup K; Pedersen E
    Acta Neurol Scand; 1984 Apr; 69(4):191-9. PubMed ID: 6377801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GABA-agonist progabide for spasticity in multiple sclerosis.
    Rudick RA; Breton D; Krall RL
    Arch Neurol; 1987 Oct; 44(10):1033-6. PubMed ID: 3632375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia.
    Marinelli L; Currà A; Trompetto C; Capello E; Serrati C; Fattapposta F; Pelosin E; Phadke C; Aymard C; Puce L; Molteni F; Abbruzzese G; Bandini F
    J Electromyogr Kinesiol; 2017 Dec; 37():84-89. PubMed ID: 28985544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progabide: a new GABA-mimetic agent in clinical use.
    Bergmann KJ
    Clin Neuropharmacol; 1985; 8(1):13-26. PubMed ID: 2983890
    [No Abstract]   [Full Text] [Related]  

  • 6. [Double-blind study of progabide in spasticity].
    Bovier P; Cambier J; Morselli PL
    Therapie; 1985; 40(3):181-5. PubMed ID: 4012663
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo.
    Casale R; Glynn CJ; Buonocore M
    Arch Phys Med Rehabil; 1995 Jul; 76(7):660-5. PubMed ID: 7605186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind crossover trial of progabide versus placebo in severe epilepsies.
    Loiseau P; Bossi L; Guyot M; Orofiamma B; Morselli PL
    Epilepsia; 1983 Dec; 24(6):703-15. PubMed ID: 6357772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
    Ziegler M; Fournier V; Bathien N; Morselli PL; Rondot P
    Clin Neuropharmacol; 1987 Jun; 10(3):238-46. PubMed ID: 2900682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.
    Martínez-Lage JM; Bossi L; Morales G; Martínez Vila E; Orofiamma B; Viteri C
    Epilepsia; 1984 Oct; 25(5):586-93. PubMed ID: 6383790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the GABA-agonist, progabide, on benign essential tremor. A controlled clinical trial.
    Mondrup K; Dupont E; Pedersen E
    Acta Neurol Scand; 1983 Oct; 68(4):248-52. PubMed ID: 6362317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of the GABA-agonist, THIP, on proprioceptive and flexor reflexes in spastic patients.
    Mondrup K; Pedersen E
    Acta Neurol Scand; 1983 Jan; 67(1):48-54. PubMed ID: 6301199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antispastic effects of Ba 34647 (B-4-p-chlorophenyl-gamma-amino-butyric acid) a GABA derivative.
    Lapierre YD; Elie R; Tetreault L
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1059-68. PubMed ID: 4154825
    [No Abstract]   [Full Text] [Related]  

  • 15. Tension development and muscle activation in the leg during gait in spastic hemiparesis: independence of muscle hypertonia and exaggerated stretch reflexes.
    Berger W; Horstmann G; Dietz V
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):1029-33. PubMed ID: 6090590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between stretch reflex thresholds and voluntary arm muscle activation in patients with spasticity.
    Musampa NK; Mathieu PA; Levin MF
    Exp Brain Res; 2007 Aug; 181(4):579-93. PubMed ID: 17476486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical treatment of spasticity--spastic movement disorders].
    Dietz V
    Nervenarzt; 2013 Dec; 84(12):1508-11. PubMed ID: 24271110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of dantrolene sodium in spasticity with low dependence on fusimotor drive.
    Knutsson E; Martensson A
    J Neurol Sci; 1976 Oct; 29(2-4):195-212. PubMed ID: 135820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progabide for refractory partial epilepsy: a controlled add-on trial.
    Schmidt D; Utech K
    Neurology; 1986 Feb; 36(2):217-21. PubMed ID: 3511402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stretch reflex dynamics in spastic elbow flexor muscles.
    Powers RK; Campbell DL; Rymer WZ
    Ann Neurol; 1989 Jan; 25(1):32-42. PubMed ID: 2913927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.